ONECUT2 and prostate cancer: In prostate cancer, ectopic ONECUT2 expression, in conjunction with hypoxia, inhibits androgen signaling and induces neuroendocrine plasticity, thereby promoting prostate neuroendocrine cell proliferation [28, 29].